{"id":53596,"date":"2023-02-02T23:02:40","date_gmt":"2023-02-02T22:02:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/"},"modified":"2023-02-02T23:02:40","modified_gmt":"2023-02-02T22:02:40","slug":"adtalem-global-education-announces-fiscal-second-quarter-2023-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/","title":{"rendered":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results"},"content":{"rendered":"
\n

\n\u00a0\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, today reported academic, operating, and financial results for its second quarter fiscal 2023 ended Dec. 31, 2022. The earnings press release and a presentation used to accompany the webcast are accessible by visiting the Investor Relations section of Adtalem\u2019s website, located at the following link: https:\/\/investors.adtalem.com\/events\/events-calendar\/default.aspx<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nAs previously announced, Steve Beard, president and chief executive officer, and Bob Phelan, senior vice president and chief financial officer, will discuss the company’s financial performance during a conference call today at 4 p.m. CST (5 p.m. EST). For those participating by telephone, dial 877-407-6184 (United States) or +1 201-389-0877 (outside the United States) and request the \u201cAdtalem Call\u201d or use conference ID: 13734624. Adtalem will also broadcast the conference call live on the web at: https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=N0txs9lD<\/a>.\n<\/p>\n

\nPlease access the website at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.\n<\/p>\n

\nAdtalem will archive a replay of the call until March 3, 2023. To access the replay, dial 877-660-6853 (United States) or +1 201-612-7415 (outside the United States), conference ID: 13734624, or visit the Adtalem website at: https:\/\/investors.adtalem.com\/overview\/default.aspx<\/a>.\n<\/p>\n

\nAbout Adtalem Global Education<\/b>\n<\/p>\n

\nAdtalem Global Education (NYSE: ATGE) is a national leader in post-secondary education and leading provider of professional talent to the healthcare industry. With a dedicated focus on driving strong outcomes that increase workforce preparedness, Adtalem empowers a diverse learner population to achieve their goals and make inspiring contributions to their communities. Adtalem is the parent organization of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. Adtalem\u2019s family of institutions has more than 300,000 alumni and 10,000 employees. Adtalem was named one of America\u2019s Most Responsible Companies in 2021 and 2023 by Newsweek and Statista, and one of America\u2019s Best Employers for Diversity in 2021 and 2022 by Forbes and Statista. Visit Adtalem.com<\/a> for more information and follow on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact<\/b>
Chandrika Nigam
\n
Chandrika.Nigam@Adtalem.com<\/a>
312-681-3209\n<\/p>\n

\nMedia Contact<\/b>
Rosalind D\u2019Eugenio
\n
Rosalind.Deugenio@adtalem.com<\/a>
312-906-6600\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u00a0 CHICAGO–(BUSINESS WIRE)–Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, today reported academic, operating, and financial results for its second quarter fiscal 2023 ended Dec. 31, 2022. The earnings press release and a presentation used to accompany the webcast are … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53596","6":"format-standard","7":"category-industry"},"yoast_head":"\nAdtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u00a0 CHICAGO–(BUSINESS WIRE)–Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, today reported academic, operating, and financial results for its second quarter fiscal 2023 ended Dec. 31, 2022. The earnings press release and a presentation used to accompany the webcast are ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T22:02:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results\",\"datePublished\":\"2023-02-02T22:02:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/\"},\"wordCount\":398,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005044\\\/en\\\/588701\\\/21\\\/AdTalem_logo_RGB_051617.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/\",\"name\":\"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005044\\\/en\\\/588701\\\/21\\\/AdTalem_logo_RGB_051617.jpg\",\"datePublished\":\"2023-02-02T22:02:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005044\\\/en\\\/588701\\\/21\\\/AdTalem_logo_RGB_051617.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005044\\\/en\\\/588701\\\/21\\\/AdTalem_logo_RGB_051617.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/","og_locale":"en_US","og_type":"article","og_title":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend","og_description":"\u00a0 CHICAGO–(BUSINESS WIRE)–Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, today reported academic, operating, and financial results for its second quarter fiscal 2023 ended Dec. 31, 2022. The earnings press release and a presentation used to accompany the webcast are ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T22:02:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results","datePublished":"2023-02-02T22:02:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/"},"wordCount":398,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/","url":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/","name":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg","datePublished":"2023-02-02T22:02:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230202005044\/en\/588701\/21\/AdTalem_logo_RGB_051617.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/adtalem-global-education-announces-fiscal-second-quarter-2023-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Adtalem Global Education Announces Fiscal Second Quarter 2023 Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53596"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53596\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}